Evidence map›Paper›PMID 28959241›Full record

ArticleFrontiers in microbiology2017

Prophylactic Supplementation of

Eduardo Mendes, Beatriz G Acetturi, Andrew M Thomas, Flaviano Dos S Martins, Amanda R Crisma, Gilson Murata, Tárcio T Braga, Niels O S Camâra, Adriana L Dos S Franco, João C Setubal and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. The Role of CD4International journal of molecular sciences · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Nutrients · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Eduardo MendesDepartment of Pharmaceutics Sciences, Institute of Environmental, Chemistry and Pharmaceutical Sciences, Universidade Federal de São PauloDiadema, Brazil.
Beatriz G AcetturiDepartment of Pharmacology, Institute of Biomedical Sciences I, University of São PauloSão Paulo, Brazil.
Andrew M ThomasMedical Genomics Laboratory, CIPE/A.C.Camargo Cancer CenterSão Paulo, Brazil.
Flaviano Dos S MartinsDepartment of Microbiology, Institute of Biological Sciences, Federal University of Minas GeraisBelo Horizonte, Brazil.
Amanda R CrismaDepartment of Physiology and Biophysics, Institute of Biomedical Sciences, University of São PauloSão Paulo, Brazil.
Gilson MurataDepartment of Physiology and Biophysics, Institute of Biomedical Sciences, University of São PauloSão Paulo, Brazil.
Tárcio T BragaDepartment of Immunology, Institute of Biomedical Sciences IV, University of São PauloSão Paulo, Brazil.
Niels O S CamâraDepartment of Immunology, Institute of Biomedical Sciences IV, University of São PauloSão Paulo, Brazil.
Adriana L Dos S FrancoPost Graduate Program in Biophotonics Applied to Health Sciences, Universidade Nove de JulhoSão Paulo, Brazil.
João C SetubalDepartment of Biochemistry, Institute of Chemistry, University of São PauloSão Paulo, Brazil.
Willian R RibeiroDepartment of Pharmaceutics Sciences, Institute of Environmental, Chemistry and Pharmaceutical Sciences, Universidade Federal de São PauloDiadema, Brazil.
Claudete J ValdugaDepartment of Pharmacy and Biotechnology, Universidade de Anhanguera de São PauloSão Paulo, Brazil.
Rui CuriDepartment of Physiology and Biophysics, Institute of Biomedical Sciences, University of São PauloSão Paulo, Brazil.
Emmanuel Dias-NetoMedical Genomics Laboratory, CIPE/A.C.Camargo Cancer CenterSão Paulo, Brazil.
Wothan Tavares-de-LimaDepartment of Pharmacology, Institute of Biomedical Sciences I, University of São PauloSão Paulo, Brazil.
Caroline M FerreiraDepartment of Pharmaceutics Sciences, Institute of Environmental, Chemistry and Pharmaceutical Sciences, Universidade Federal de São PauloDiadema, Brazil.
Universidade de São Paulo · BRUniversidade Federal de São Paulo · BRAC Camargo Hospital · BRAnhanguera-Uniderp University · BRUniversidade Federal de Minas Gerais · BRUniversidade Nove de Julho · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asthma is a chronic inflammatory disease that affects more females than males after puberty, and its symptoms and severity in women change during menstruation and menopause. Recently, evidence has demonstrated that interactions among the microbiota, female sex hormones, and immunity are associated with the development of autoimmune diseases. However, no studies have investigated if therapeutic gut microbiota modulation strategies could affect asthma exacerbation during menstruation and menopause. Here we aimed to examine the preventive effects of a probiotic,

Indexed as

airway inflammationBifidobacterium longummicrobiotaovariectomyprobiotic

Identifiers

PMID28959241
PMCPMC5604069
OpenAlexW2755888548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.